SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-104267
Filing Date
2022-04-13
Accepted
2022-04-13 16:06:01
Documents
11
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d307419ddef14a.htm DEF 14A 359732
2 GRAPHIC g307419dsp044b.jpg GRAPHIC 8176
3 GRAPHIC g307419dsp044c.jpg GRAPHIC 8105
4 GRAPHIC g307419dsp044d.jpg GRAPHIC 8320
5 GRAPHIC g307419dsp044f.jpg GRAPHIC 8369
6 GRAPHIC g307419dsp044n.jpg GRAPHIC 8283
7 GRAPHIC g307419dsp045a.jpg GRAPHIC 8085
8 GRAPHIC g307419dsp045b.jpg GRAPHIC 8134
9 GRAPHIC g307419g00n00.jpg GRAPHIC 4539
10 GRAPHIC g307419g0412083455169.jpg GRAPHIC 2035
11 GRAPHIC g307419g52u01.jpg GRAPHIC 55888
  Complete submission text file 0001193125-22-104267.txt   483184
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38692 | Film No.: 22824771
SIC: 2834 Pharmaceutical Preparations